November 26, 2017
VUNO participated in the RSNA this year for the second time, and introduced various AI-based
diagnostic solutions. We had two booths there: our main booth in the North Hall and another
one in Machine Learning Pavilion. Thankfully, many people from various corporates, hospitals,
and schools paid us a visit. We mainly presented VUNO-Med BoneAge, which is at its last stage
to be approved in Korea, as well as VUNO-Med Chest X-ray and Chest CT products which find
abnormalities and locate lesions in chest X-rays/CTs. There we were reassured that our technology
is relatively superior to the products of other competitors.
The results that were presented this year will be approved or will be applied to be
approved in 2018, and we will focus on R&D and commercialization of more official
commercial products in order to offer beneficial products to our customers.
We ask for your continuous support.
Thanks for subscribing to our newsletter.